All articles by  

  1. Researchers develop genomic barcode to track immune cells

    A Garvan Institute of Medical Research team in Australia has created a genomic barcode to identify immune cells that recognise…
    Read More…

    17 Jul
  2. Sosei Heptares and Genentech enter GPCR target alliance

    Japanese biopharmaceutical group Sosei Heptares has partnered with Roche subsidiary Genentech for the discovery and development of drugs that modulate…
    Read More…

    17 Jul
  3. Kite to open new manufacturing plant for cell therapies

    Gilead Sciences subsidiary Kite Therapeutics will build a new facility in Oceanside, California, US, to develop and manufacture viral vectors,…
    Read More…

    17 Jul
  4. Boehringer acquires AMAL Therapeutics for $366m

    Boehringer Ingelheim has expanded its cancer immunology portfolio with the acquisition of Swiss biotechnology firm AMAL Therapeutics for up to…
    Read More…

    16 Jul
  5. Oklahoma seeks $17bn from J&J for opioid crisis

    Lawyers for the US state of Oklahoma have argued that Johnson & Johnson (J&J) should be held responsible for driving…
    Read More…

    16 Jul
  6. Recursion secures funds to support AI-based drug discovery

    Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding round led by the…
    Read More…

    16 Jul
  7. AstraZeneca’s Imfinzi cancer drug secures orphan status in US

    The US Food and Drug Administration (FDA) has awarded orphan drug designation (ODD) to AstraZeneca’s Imfinzi (durvalumab) in small cell…
    Read More…

    15 Jul
  8. Gilead and Galapagos deepen R&D alliance with ten-year deal

    Gilead Sciences has expanded its partnership with Belgian biotech company Galapagos with a ten-year global research and development (R&D) deal….
    Read More…

    15 Jul
  9. Recordati acquires rights to Signifor and osilodrostat from Novartis

    Recordati has agreed to acquire the global rights to two of Novartis’ medicines, Signifor and osilodrostat, for the treatment of…
    Read More…

    15 Jul
  10. US researchers develop ‘EpiPen’ to treat injured spinal cords

    Researchers at the University of Michigan in the US have developed a nanoparticles injection to prevent the immune system from…
    Read More…

    12 Jul
Close
Close
Close

Go Top